A one-shot CRISPR-based gene remedy developed by Vertex Prescription drugs and CRISPR Therapeutics now has extra FDA approval as a therapy for the uncommon blood illness beta-thalassemia. The optimistic choice introduced Tuesday for the remedy, Casgevy, was broadly anticipated after its approval in December for the therapy of sickle cell illness, however comes greater than two months early. The goal […]
